Programmed-death ligand 1 (PD-L1) is a 33 kDa type I glycoprotein belonging to the B7 protein family that functions as an immune checkpoint. PD-L1 is typically expressed by tumor and antigen presenting cells and binds the receptor programmed-death 1 (PD-1). During homeostasis the PD-L1/PD-1 signaling axis helps prevent autoimmunity, but in the tumor microenvironment it inhibits T cell activity and promotes tumor cell escape. We offer PD-L1 antibodies that have been featured in 70+ publications, including 4- and 5-star customer reviewed antibodies. Browse our catalog of rabbit monoclonal, monoclonal, polyclonal, and PD-L1-conjugated antibodies. Validated research applications for these MUC5AC-antibodies include Blocking/Neutralizing, CyTOF-Ready, ELISA, Flow Cytometry, ICC, Immunofluorescence, IHC-Frozen, IHC-Paraffin, Knockdown, Simple Western, and Western Blot. Our PD-L1 antibodies are reactive in Human, Mouse, Primate, and Rat. Choose the anti-PD-L1 antibody best suited for your research needs by viewing the technical details, images, references, reviews, and related products. Each PD-L1 antibody is fully covered by Novus’ Guarantee+.
Alternate Names for PD-L1 Antibodies
anti-Avelumab antibody, anti-B7-H antibody, anti-B7H1 antibody, anti-B7-H1 antibody, anti-B7H1PDCD1L1 antibody, anti-CD274 antigenMGC142294 antibody, anti-CD274 molecule antibody, anti-CD274 antibody, anti-PDCD1L1 antibody, anti-PDCD1LG1 antibody, anti-PDCD1LG1MGC142296 antibody, anti-PDL1 antibody, anti-PD-L1 antibody, anti-PD-L1B7 homolog 1 antibody, anti-PDL1PDCD1 ligand 1 antibody, anti-programmed cell death 1 ligand 1 antibody, anti-Programmed death ligand 1 antibody
19 Results for "pd-l1" in Primary Antibodies